INS and type 1 diabetes mellitus: Our data from a randomised, two-period crossover study comparing closed-loop insulin delivery using diluted vs standard insulin aspart in young children with type 1 diabetes suggest no significant differences in aspart pharmacokinetics between the two strengths except for reduced intersubject variability in tmax following administration of diluted aspart.